Obesity is a chronic disease that increases the risk of serious health conditions such as heart disease, stroke, diabetes, and certain cancers. With 4 out of 10 American adults living with obesity, access to treatment options and insurance coverage is crucial.
The Treat and Reduce Obesity Act (TROA) aims to expand Medicare coverage to include screening and treatment for obesity, as well as coverage of FDA-approved medications for chronic weight management. Similar legislation is being introduced at the state level.
Learn about the real-world impacts, including the economic toll, that a lack of obesity treatment coverage has on women.
Opening Remarks
Beth Battaglino, RN-C
President and CEO, HealthyWomen
Moderator
Elizabeth Garner, M.D., MPH
Immediate Past President, American Medical Women’s Association
Former Chief Scientific Officer, Ferring Pharmaceuticals
Speakers
Chad D. Meyerhoefer, Ph.D.
Chair of the Department of Economics, Lehigh University
Research Associate, National Bureau of Economic Research
Thank you to our briefing co-sponsors:
This educational resource was created with support from Eli Lilly and Company.
